INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| May 25, 2018 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Other acquisition or disposition | -- | -- | 4,660 |
| Jan 09, 2006 |
SVP, PreclinDevel & Biomol Sci
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 57 | $16.98 | 4,660 |
| Dec 18, 2009 |
SVP Res and Dev Sciences
|
SVP Res and Dev Sciences | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 4,705 | -- | 4,705 |
| Jan 09, 2006 |
SVP, PreclinDevel & Biomol Sci
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 65 | $16.92 | 4,717 |
| Jan 09, 2006 |
SVP, PreclinDevel & Biomol Sci
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 57 | $16.91 | 4,782 |
| Jan 09, 2006 |
SVP, PreclinDevel & Biomol Sci
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 17 | $16.88 | 4,839 |
| Jan 09, 2006 |
SVP, PreclinDevel & Biomol Sci
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 15 | $16.89 | 4,856 |
| Nov 18, 2005 |
SVP, PreclinDevel & Biomol Sci
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Bona fide gift | 500 | -- | 4,871 |
| Dec 18, 2006 |
SVP, Therap & Clin Prog Dev
|
SVP, Therap & Clin Prog Dev | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 4,921 | -- | 4,921 |
| Jun 23, 2017 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Other acquisition or disposition | -- | -- | 5,000 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.